{"text_format":"2","workbook":"xls","n_sheets":1,"sheets":["report2"],"not_rendered":{"charts":0,"images":0,"macros":0,"external_links":1,"defined_names":1,"comments":0,"pivot_tables":0},"unopened":[],"bounds":{"document_bytes":16777216,"sheet_cells":100000,"run_cost":"one","rows_first":2000,"rows_last":500,"rows_between":2000,"halvings":0,"cell_chars":16384,"cell_head_chars":4096},"cells_cut":0,"cells_raw":0,"read":"whole","date_system":"1900","formulas":"cached_only"}

{"sheet":"report2","index":0,"n_rows":30,"n_cols":5,"rows_kept":30,"cut":false,"hidden":false,"merged":[[0,2,0,3],[0,4,0,5],[1,2,1,3],[1,4,1,5],[2,2,2,3],[3,2,3,3],[10,2,10,3],[11,2,11,3],[12,2,12,3],[13,2,13,3],[22,2,22,3],[23,2,23,3],[27,2,27,3]],"flags":["formulas_cached_only"]}
[null,"1.","Record Nr.",null,"UNINA9910970999303321"]
[null,null,"Titolo",null,"Immunization safety review : hepatitis B vaccine and demyelinating neurological disorders / / Kathleen Stratton, Donna A. Almario, and Marie C. McCormick, editors"]
[null,null,"Pubbl/distr/stampa",null,"Washington, D.C. ; ; [Great Britain], : National Academies Press, c2002"]
[null,null,"ISBN",null,"9786610183555"]
[{"$nulls":4},"9780309182836"]
[{"$nulls":4},"0309182832"]
[{"$nulls":4},"9781280183553"]
[{"$nulls":4},"1280183551"]
[{"$nulls":4},"9780309566100"]
[{"$nulls":4},"030956610X"]
[null,null,"Edizione",null,"[1st ed.]"]
[null,null,"Descrizione fisica",null,"1 online resource (xiv, 106 pages) : illustrations"]
[null,null,"Disciplina",null,"614.593"]
[null,null,"Soggetti",null,"Hepatitis B - Vaccination"]
[{"$nulls":4},"Hepatitis B vaccine"]
[{"$nulls":4},"Demyelination - Vaccination"]
[{"$nulls":4},"Immunization - Complications"]
[{"$nulls":4},"Vaccination - Complications"]
[{"$nulls":4},"Hepatitis B Vaccines - adverse effects"]
[{"$nulls":4},"Demyelinating Diseases - etiology"]
[{"$nulls":4},"Health Policy"]
[{"$nulls":4},"United States"]
[null,null,"Lingua di pubblicazione",null,"Inglese"]
[null,null,"Formato",null,"Materiale a stampa"]
[null,null,null,"Livello bibliografico","Monografia"]
[null,null,null,"Note generali","Bibliographic Level Mode of Issuance: Monograph"]
[null,null,null,"Nota di bibliografia","Includes bibliographical references (p. 85-90)."]
[null,null,"Nota di contenuto",null,"IMMUNIZATION SAFETY REVIEW -- Copyright -- Acknowledgments -- Contents -- Executive Summary -- ABSTRACT -- DEMYELINATING NEUROLOGICAL DISORDERS -- HEPATITIS B VIRAL INFECTION -- HEPATITIS B VACCINE -- EVIDENCE REVIEWED BY THE COMMITTEE -- CAUSALITY ASSESSMENT -- BIOLOGICAL MECHANISMS ASSESSMENT -- SIGNIFICANCE ASSESSMENT -- RECOMMENDATIONS FOR PUBLIC HEALTH RESPONSE -- Policy Review -- Research -- Surveillance -- Basic and Clinical Science -- Communication -- REFERENCES -- Immunization Safety Review: Hepatitis B Vaccine and Demyelinating "]
[{"$nulls":4},"Neurological Disorders -- THE CHARGE TO THE COMMITTEE -- THE STUDY PROCESS -- THE FRAMEWORK FOR SCIENTIFIC ASSESSMENT -- Causality -- Biological Mechanisms -- Terminology -- Categories of Evidence -- Published and Unpublished Data -- UNDER REVIEW: HEPATITIS B VACCINE AND DEMYELINATING NEUROLOGICAL DISORDERS -- Adverse Neurological Events -- Multiple Sclerosis -- Acute Disseminated Encephalomyelitis -- Optic Neuritis -- Transverse Myelitis -- Guillain-Barré Syndrome -- Peripheral Neuritis -- Hepatitis B Virus Infection and Hepatitis B Vaccines -- SCIENTIFIC ASSESSMENT -- Causality -- Case Reports -- Multiple Sclerosis -- Causality Argument -- First Episode of a Central Nervous System Demyelinating Disorder -- Acute Disseminated Encephalomyelitis -- Optic Neuritis -- Transverse Myelitis -- Brachial Neuritis -- Biological Mechanisms -- Immune-Mediated Processes in MS and Other Demyelinating White-Matter Diseases -- Theoretical Mechanisms for Infection-Induced Immune-Mediated Injury -- Theoretical Mechanisms for Vaccine-Induced Demyelinating Diseases -- Evidence from Animal Models for a Possible Role for Hepatitis B Vaccine in Demyelination -- Evidence from Humans -- Known Effects of Other Vaccines -- Conclusions Regarding Biological Mechanisms -- SIGNIFICANCE ASSESSMENT."]
[{"$nulls":4},"Disease Burden Associated with Multiple Sclerosis -- Hepatitis B Vaccine Safety Concerns in France -- Hepatitis B Virus Infection -- Prevention Strategies -- Acceptance of the Hepatitis B Vaccine in the United States -- Information on the Safety of the Hepatitis B Vaccine -- Conclusions -- RECOMMENDATIONS FOR PUBLIC HEALTH RESPONSE -- Policy Review -- Research -- Surveillance -- Basic and Clinical Science -- Communication -- SUMMARY -- REFERENCES -- Appendix A Committee Conclusions and Recommendations from Previous Reports -- MEASLES-MUMPS-RUBELLA VACCINE AND AUTISM -- Conclusions -- Recommendations -- Public Health Response -- Policy Review -- Research Regarding MMR and ASD -- Communications -- THIMEROSAL-CONTAINING VACCINES AND NEURODEVELOPMENTAL DISORDERS -- Conclusions -- Public Health Response Recommendations -- Policy Review and Analysis -- Public Health and Biomedical Research -- Epidemiological Research -- Clinical Research -- Basic Science Research -- MULTIPLE IMMUNIZATIONS AND IMMUNE DYSFUNCTION -- Conclusions -- Scientific Assessment -- Causality Conclusions -- Biological Mechanisms Conclusions -- Significance Assessment -- Public Health Response Recommendations -- Policy Review -- Research -- Epidemiological Research -- Basic Science and Clinical Research -- Communication -- Appendix B Public Meeting Agenda March 11, 2002 -- Appendix C Chronology of Important Events Regarding Vaccine Safety."]